Scilex Pharmaceuticals Inc. — Form D/A
Scilex Pharmaceuticals Inc. of MALVERN, PA, a company, filed a Form D amendment with the SEC on 2014-08-04. The offering totals $5.3M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-08-04
- Form: D/A
- Accession: 0000905718-14-000492
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $5.0M
- Remaining: $248K
- Minimum investment: $100
- Investors: 12
- Date of first sale: 2014-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-214267
Issuer
- Name: Scilex Pharmaceuticals Inc.
- CIK: 0001603542
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 301 LINDENWOOD DR., MALVERN, PA, 19355
- Phone: 610-644-5352
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Eric Floyd | Director | Berwyn, PA |
| William Pedranti | Director | San Diego, CA |
| William Pedranti | Executive Officer | San Diego, CA |
| Anthony Mack | Director | Malvern, PA |
| Anthony Mack | Executive Officer | Malvern, PA |
| Jerrold Sendrow | Director | Malvern, PA |
| Jerrold B Sendrow | Director | Malvern, PA |
| Anthony P Mack | Director | West Chester, PA |
| Anthony P Mack | Executive Officer | West Chester, PA |
| Eric P Floyd | Director | West Chester, PA |
| Richard B Cohen | Executive Officer | Santa Monica, CA |
Other filings by this issuer (4)
More